» Articles » PMID: 4116138

Biophysical and Biochemical Heterogeneity of Purified Hepatitis B Antigen

Overview
Journal J Virol
Date 1972 Sep 1
PMID 4116138
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatitis B antigen of the D (a+, d+, y-) subtype was purified from plasma of apparently healthy persons and from hepatitis patients. The original samples contained 20- and 42-nm particles and tubular forms (20-nm diameter). Ultracentrifugation during the purification procedure yielded pellets which were then treated at pH 2.4. Both the large, 42-nm Dane particles and the tubular forms were lost during the acid treatment of the pelleted particles, yielding a preparation containing a mixture of particles approximately 20 and 25 nm in diameter. This difference in size was substantiated in that two distinct molecular weights were calculated from high-speed equilibrium data, 3.6 x 10(6) and 4.5 x 10(6). Further heterogeneity was observed in that hepatitis B antigenic activity was present in purified particles with an isoelectric pH of 4.0 and also in those with a pH of 4.4. No significant differences were observed in the gross amino acid composition of purified antigen obtained from plasma of three different persons. (125)I-labeled, purified antigen was found to contain six distinct polypeptides with molecular weights ranging from 10,000 to 39,000.

Citing Articles

Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.

Ho J, Jeevan-Raj B, Netter H Viruses. 2020; 12(2).

PMID: 31973017 PMC: 7077199. DOI: 10.3390/v12020126.


Extrahepatic manifestations of hepatitis B virus infection: Addison's disease and myelofibrosis in a patient with persistent hepatitis B surface antigenemia.

Somlo F, Berry G Can J Infect Dis. 2012; 4(3):139-44.

PMID: 22346436 PMC: 3250782. DOI: 10.1155/1993/393861.


Immunological and biophysical alteration of hepatitis B virus antigens by sodium hypochlorite disinfection.

Sehulster L, Hollinger F, Dreesman G, Melnick J Appl Environ Microbiol. 1981; 42(5):762-7.

PMID: 7316505 PMC: 244104. DOI: 10.1128/aem.42.5.762-767.1981.


New radioimmunoadsorbent method for detection of hepatitis B surface antigen.

Moore R, Carpenter S, Swartzell C, Schick L J Clin Microbiol. 1982; 15(4):617-24.

PMID: 7068838 PMC: 272156. DOI: 10.1128/jcm.15.4.617-624.1982.


Immunodiagnosis of hepatitis B with high-affinity IgM monoclonal antibodies.

Wands J, Carlson R, Schoemaker H, Isselbacher K, Zurawski Jr V Proc Natl Acad Sci U S A. 1981; 78(2):1214-8.

PMID: 6940137 PMC: 319978. DOI: 10.1073/pnas.78.2.1214.


References
1.
Summers D, Maizel Jr J, Darnell Jr J . Evidence for virus-specific noncapsid proteins in poliovirus-infected HeLa cells. Proc Natl Acad Sci U S A. 1965; 54(2):505-13. PMC: 219696. DOI: 10.1073/pnas.54.2.505. View

2.
McCombs R, Melnick M, Brunschwig J . Biophysical studies of vesicular stomatitis virus. J Bacteriol. 1965; 91(2):803-12. PMC: 314933. DOI: 10.1128/jb.91.2.803-812.1966. View

3.
Bayer M, Blumberg B, Werner B . Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis. Nature. 1968; 218(5146):1057-9. DOI: 10.1038/2181057a0. View

4.
Levene C, Blumberg B . Additional specificities of Australia antigen and the possible identification of hepatitis carriers. Nature. 1969; 221(5176):195-6. DOI: 10.1038/221195a0. View

5.
DANE D, Cameron C, Briggs M . Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet. 1970; 1(7649):695-8. DOI: 10.1016/s0140-6736(70)90926-8. View